Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors 2021-08-16 20:00
BioAgilytix to Purchase Australia-based 360biolabs® 2021-08-16 18:00
Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19 2021-08-16 15:29
Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market 2021-08-16 14:14
Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange 2021-08-16 13:12
GeneQuantum announces a key leadership appointment 2021-08-16 10:00
InxMed's IN10018 Receives U.S. FDA Fast Track Designation for the Treatment of Platinum-resistant Ovarian Cancer 2021-08-16 09:31
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India 2021-08-16 08:00
TurtleTree and Solar Biotech enter strategic partnership 2021-08-13 21:00
A3P Biomedical AB: Fast track publication of the STHLM3 MRI trial in The Lancet Oncology 2021-08-13 12:22
TOT BIOPHARM Anounces 2021 Interim Results 2021-08-13 10:59
WuXi AppTec Reports Strong 2021 Interim Results 2021-08-12 17:52
NUHS Embarks on Holomedicine Research in Singapore, Using Mixed Reality Technology to Enhance Diagnosis, Education and Patient Care 2021-08-12 15:00
Innovent Announces IBI306 (anti-PCSK-9 antibody) Meets the Primary Endpoint in a Phase 3 Clinical Study for Chinese Heterozygous Familial Hypercholesterolemia 2021-08-12 08:00
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002 2021-08-12 08:00
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director 2021-08-11 20:31
Technology Investments will Help Oncology Practices Succeed in Value-based Care 2021-08-11 18:02
ImmVira's MVR-T3011 IV Completed First Dosing for Intravenous Administration in a U.S. Phase I Clinical Trial 2021-08-11 10:45
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration 2021-08-11 01:00
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China 2021-08-10 23:39
1 229 230 231 232 233 453